Testing effectiveness (Phase 2)UnknownNCT02797626
What this trial is testing
Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)
Who this might be right for
Stage II A/B Seminomatous Germ Cell Tumors
Heinrich-Heine University, Duesseldorf 30